Eosinophilic Globules in Bronchoalveolar Lavage Fluid of Patients With Systemic Sclerosis-Related Interstitial Lung Disease A Diagnostically Useful, Previously Unreported Finding in a Retrospective and Prospective Study, Including Differential Diagnosis With Other Idiopathic and Secondary Interstitial Lung Diseases

被引:2
|
作者
Rossi, Giulio [1 ]
Andreani, Alessandro [1 ]
Morandi, Paola [1 ]
Marchioni, Alessandro [1 ]
Corradini, Paolo [1 ]
Cappiello, Gaia [1 ]
Bortolotti, Monica [1 ]
Qosja, Ardian [1 ]
Manzini, Carlo [1 ]
Fmi, Clodoveo [1 ]
Richeldi, Luca [1 ]
Cavazza, Alberto [1 ]
机构
[1] Univ Policlin Modena, Azienda Osped, Sect Pathol Anat, I-41100 Modena, Italy
关键词
Bronchoalveolar lavage; Systemic sclerosis; Interstitial pneumonia; Periodic acid-Schiff; Collagen;
D O I
10.1309/AJCPJ6W9XOFEXIYS
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Bronchoalveolar lavage (BAL) is a minimally invasive method possibly representing a diagnostic tool in the evaluation of interstitial lung diseases (ILDs) of different causes. We first describe herein the morphologic, histochemical, and immunohistochemical features of previously unreported eosinophilic globular deposits of acellular amorphous material of uncertain nature in a relatively large series of 227 BAL samples obtained from patients with various ILDs. Overall, eosinophilic globules were detected in 18 cases (7.9%), 16 of which were in patients with systemic sclerosis (SSc)-related ILD (16/50 [32%]) and in 2 cases of apparently idiopathic usual interstitial pneumonia. Apart from the possible diagnostic information of this finding, in patients with SSc, the globules were significantly related to BAL neutrophilia or eosinophilia and extensive ILD in high-resolution computed tomography (P < .0001). Differential diagnosis with other types of acellular globular materials observed in BAL samples is also discussed.
引用
收藏
页码:927 / 933
页数:7
相关论文
共 7 条
  • [1] Bronchoalveolar lavage fluid cytokines in the assessment of interstitial lung disease in systemic sclerosis: a prospective study
    Mittal, Saurabh
    Kumar, Uma
    Guleria, Randeep
    Mohan, Anant
    Madan, Karan
    Bhalla, Ashu Seith
    Mathur, Sandeep
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [2] PROGNOSIS OF PATIENTS WITH SYSTEMIC SCLEROSIS-RELATED INTERSTITIAL LUNG DISEASE AFTER THE LUNG TRANSPLANTATION: A RETROSPECTIVE STUDY
    Nakayama, Y.
    Nakashima, R.
    Handa, T.
    Ohsumi, A.
    Yamada, Y.
    Nakajima, D.
    Yutaka, Y.
    Tanaka, S.
    Hamada, S.
    Ikezoe, K.
    Tanizawa, K.
    Shirakashi, M.
    Hiwa, R.
    Tsuji, H.
    Kitagori, K.
    Akizuki, S.
    Yoshifuji, H.
    Date, H.
    Morinobu, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 160 - 161
  • [3] Prognosis of patients with systemic sclerosis-related interstitial lung disease on the lung transplant waiting list: a retrospective study
    Nakayama, Yoichi
    Nakashima, Ran
    Handa, Tomohiro
    Ohsumi, Akihiro
    Yamada, Yoshito
    Nakajima, Daisuke
    Yutaka, Yojiro
    Tanaka, Satona
    Hamada, Satoshi
    Ikezoe, Kohei
    Tanizawa, Kiminobu
    Shirakashi, Mirei
    Hiwa, Ryosuke
    Tsuji, Hideaki
    Kitagori, Koji
    Akizuki, Shuji
    Yoshifuji, Hajime
    Date, Hiroshi
    Morinobu, Akio
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [4] Prognosis of patients with systemic sclerosis-related interstitial lung disease on the lung transplant waiting list: a retrospective study
    Yoichi Nakayama
    Ran Nakashima
    Tomohiro Handa
    Akihiro Ohsumi
    Yoshito Yamada
    Daisuke Nakajima
    Yojiro Yutaka
    Satona Tanaka
    Satoshi Hamada
    Kohei Ikezoe
    Kiminobu Tanizawa
    Mirei Shirakashi
    Ryosuke Hiwa
    Hideaki Tsuji
    Koji Kitagori
    Shuji Akizuki
    Hajime Yoshifuji
    Hiroshi Date
    Akio Morinobu
    Scientific Reports, 13
  • [5] Activin A And Follistatin Like-3 Levels In Bronchoalveolar Lavage Fluid Of Patients With Systemic Sclerosis Related Interstitial Lung Disease
    Karagiannis, K.
    Sato, H.
    Stock, C.
    Handa, T.
    Antoniou, K. M.
    Maher, T. M.
    Wells, A. U.
    Lindahl, G.
    Renzoni, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [6] Comparison of the effectiveness of cyclophosphamide and rituximab treatment in patients with systemic sclerosis-related interstitial lung diseases: a retrospective, observational cohort study
    Yilmaz, Deniz Demir
    Borekci, Sermin
    Musellim, Benan
    CLINICAL RHEUMATOLOGY, 2021, 40 (10) : 4071 - 4079
  • [7] Treatment with nintedanib is as effective and safe in patients with other connective tissue diseases (CTDs)-interstitial lung disease (ILD) as in patients with systemic sclerosis-ILD: A multicenter retrospective study
    Misirci, Salim
    Ekin, Ali
    Yagiz, Burcu
    Coskun, Belkis Nihan
    Basibuyuk, Fatma
    Birlik, Ahmet Merih
    Sari, Ismail
    Karaca, Aylin Dolu
    Koca, Suleyman Serdar
    Cetin, Gozde Yildirim
    Okyar, Burak
    Atilla, Nurhan
    Dalkilic, Ediz
    Pehlivan, Yavuz
    CLINICAL RHEUMATOLOGY, 2025, 44 (03) : 1187 - 1195